Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review

Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review

Abstract Background Dermatomyositis with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody has a distinct phenotype associated with small hand joint arthritis, mucocutaneous ulceration, palmar papules and less muscle involvement. It is also associated with increased risk...

Full description

Bibliographic Details
Main Authors:	Tsz-Wing Yeung, Kai-Ning Cheong, Yu-Lung Lau, Kei-Chiu Niko Tse
Format:	Article
Language:	English
Published:	BMC 2021-06-01
Series:	Pediatric Rheumatology Online Journal
Subjects:	Juvenile dermatomyositis Anti-melanoma differentiation-associated gene 5 antibody Interstitial lung disease Pneumomediastinum Myositis-specific antibodies
Online Access:	https://doi.org/10.1186/s12969-021-00595-1

Similar Items

Successful treatment of rapidly progressive interstitial lung disease complicated by a refractory pneumomediastinum in a patient with anti‐MDA5 antibody‐positive dermatomyositis
by: Lili Jiang, et al.
Published: (2023-12-01)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
by: Caitlan S. Pinotti, et al.
Published: (2023-03-01)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
by: Lauren M. Pachman, et al.
Published: (2023-10-01)

JUVENILE DERMATOMYOSITIS
by: Sigrid Covaci, et al.
Published: (2016-12-01)

The Vasculopathy of Juvenile Dermatomyositis
by: Charalampia Papadopoulou, et al.
Published: (2018-10-01)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
by: Takayuki Kishi, et al.
Published: (2021-03-01)

Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping
by: Samuel Katsuyuki Shinjo, et al.
Published: (2018-10-01)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
by: Oksana Boyarchuk, et al.
Published: (2022-08-01)

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
by: Abhinav K. Misra, et al.
Published: (2021-11-01)

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
by: Ho So, et al.
Published: (2022-02-01)

Subcutaneous Emphysema, Pneumomediastinum and Pneumothorax in a Patient with Dermatomyositis
by: Mehdi Bakhsaee, et al.
Published: (2017-03-01)

Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
by: Minfei Hu, et al.
Published: (2023-11-01)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
by: Yuan Xue, et al.
Published: (2023-01-01)

Clinical features and risk factors of lung cancer in elderly patients with dermatomyositis
by: Baiyu Zhou, et al.
Published: (2023-05-01)

A less common case of anti‐MDA5 and anti‐Ro52 antibody‐positive juvenile dermatomyositis complicated with macrophage activation syndrome
by: Li Zhang, et al.
Published: (2024-03-01)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
by: Xixia Chen, et al.
Published: (2022-08-01)

Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective
by: C. Boros, et al.
Published: (2022-11-01)

Case Report: Simultaneously Developed Amyopathic Dermatomyositis and Autoimmune Sclerosing Cholangitis – a Coincidence or a Shared Immunopathogenesis?
by: Tomislav Ledenko, et al.
Published: (2022-02-01)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
by: Chenghua Weng, et al.
Published: (2023-02-01)

Spontaneous Pneumomediastinum and Subcutaneous Emphysema in Dermatomyositis: A Case Series and Literature Review
by: Subki AH, et al.
Published: (2023-04-01)

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
by: Huyan Wang, et al.
Published: (2023-07-01)

Anasarca as the presenting symptom of juvenile dermatomyositis: a case series
by: Emily E. Schildt, et al.
Published: (2021-08-01)

Diffuse large B‐cell lymphoma in a patient with dermatomyositis‐associated interstitial lung disease: A case report
by: Shan Li, et al.
Published: (2019-10-01)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
by: Fang Chen, et al.
Published: (2022-05-01)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
by: Toshiya Hiramatsu, et al.
Published: (2022-01-01)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017-01-01)

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
by: Hanna Kim, et al.
Published: (2020-04-01)

Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01)

The Macklin effect in tension pneumomediastinum in a patient with interstitial pneumonia
by: Hiroko Watanabe, et al.
Published: (2022-11-01)

Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review
by: Jingyi Xia, et al.
Published: (2021-11-01)

Management of Myositis-Associated Interstitial Lung Disease
by: Tomoyuki Fujisawa
Published: (2021-04-01)

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature
by: Yingjie Xu, et al.
Published: (2021-01-01)

Chemotherapy induced juvenile dermatomyositis: a novel presentation- a case report
by: Keta Vagha, et al.
Published: (2022-10-01)

Juvenile Dermatomyositis with Generalized Edema
by: J Gordon Millichap
Published: (2001-06-01)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)

Symptomatic macroglossia and tongue myositis in Dermatomyositis
by: Ajili Faida, et al.
Published: (2013-04-01)

High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease
by: Ryoko Egashira
Published: (2021-07-01)

Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies
by: Arthur Felix, et al.
Published: (2023-10-01)